Home » 2015 » October

Monthly Archives: October 2015

The Elephant Rope

The Elephant Rope As a man was passing the elephants, he suddenly stopped, confused by the fact that these huge creatures were being held by only a small rope tied to their front leg. No chains, no cages. It was obvious that the elephants could, at anytime, break away from their bonds but for some reason, they did not. He ... Read More »

GSK exercises option for inhaled therapeutics from Liquidia Technologies

GSK exercises option for inhaled therapeutics from Liquidia Technologies GlaxoSmithKline (GSK) has exercised an option that gives it the exclusive rights to research, develop and commercialize inhaled therapeutics derived from Liquidia Technologies’ PRINT technology. Under a collaboration and option agreement signed in June 2012, Liquidia was entitled to receive an upfront payment including cash and equity, R&D funding, and possible ... Read More »

Torrent Pharma board approves Zyg Pharma’s amalgamation

Torrent Pharma board approves Zyg Pharma’s amalgamation It will result in concentrated management focus and synergies of operations and facilitating inter transfer of resources and optimum utilisation of assets Torrent Pharmaceuticals’ board has given nod to the scheme of amalgamation of its subsidiary Zyg Pharma with the company. The Board of Directors of the company “has approved the scheme of amalgamation ... Read More »

Crows in the Kingdom

Crows in the Kingdom One day Emperor Akbar and Birbal were taking a walk in the palace gardens. It was a nice summer morning and there were plenty of crows happily playing around the pond. While watching the crows, a question came into Akbar’s head. He wondered how many crows were there in his kingdom. Since Birbal was accompanying him, ... Read More »

Siemens Healthcare joins CANCER-ID

Siemens Healthcare joins CANCER-ID Siemens Healthcare has joined the CANCER-ID consortium, an initiative of the European Union’s Innovative Medicines Initiative (IMI), to explore the potential of blood-based biomarkers to revolutionize the detection and treatment of cancer. This consortium currently includes 33 partners from 13 countries working together to establish standard protocols for the clinical validation of blood-based biomarkers. These biomarkers, ... Read More »

GlaxoSmithKline Pharmaceuticals acquires the Vaccines business of Novartis and divests its Oncology business to Novartis

GlaxoSmithKline Pharmaceuticals acquires the Vaccines business of Novartis and divests its Oncology business to Novartis GlaxoSmithKline Pharmaceuticals (‘GSK India’) announces completion of its transaction with Novartis Healthcare (‘Novartis India’), where GSK India acquires Novartis’ vaccines business and divests its marketed oncology portfolio to Novartis India. This follows a global transaction between GlaxoSmithKline plc, UK (GSK) and Novartis AG, Switzerland (Novartis) ... Read More »

The Cracked Pot

The Cracked Pot “A water bearer in India had two large pots, each hung on each end of a pole which he carried across his neck. One of the pots had a crack in it, and while the other pot was perfect and always delivered a full portion of water at the end of the long walk from the stream ... Read More »

Dr Reddy’s launch new generic in the US

Dr Reddy’s launch new generic in the US Dr Reddy’s announces the launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg and 40 mg Dr Reddy’s Laboratories has announced that it has launched ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES USP, 20 mg and 40 mg in the US market, following the approval by the United States Food and Drug Administration (US FDA). ... Read More »

BIGTheme.net • Free Website Templates - Downlaod Full Themes